{"id":"n_wamrm7pp5nuplypvhysq","seq":13123664,"kind":"press_release","title":"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX","url":"https://www.globenewswire.com/news-release/2026/11/19/3407194/673/en/rosen-national-trial-counsel-encourages-tenax-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tenx.html","summary":"NEW YORK, Nov. 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between November 13, 2023 and August 7, 2026, both dates inclusive (the “Class Period”), of the important December 28, 2026 lead plaintiff deadline .","published":"2026-11-19T23:01:00Z","seen":"2026-11-19T23:47:50Z","lang":"en","country":"US","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com"},"via":"globenewswire-all","topics":["business"],"story":"st_ekfjni4y56rlecafxkea","category":"economy-business","category_p":0.64,"sentiment":"neutral","tone":-0.08,"political":0.13}